191 related articles for article (PubMed ID: 22299822)
1. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
4. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Costimulation Blockade-Induced Regulatory T Cells Demonstrate Dominant and Specific Tolerance to Porcine Islet Xenografts.
Wu J; Hu M; Qian YW; Hawthorne WJ; Burns H; Liuwantara D; Alexander SI; Yi S; O'Connell PJ
Transplantation; 2017 Jul; 101(7):1587-1599. PubMed ID: 27653300
[TBL] [Abstract][Full Text] [Related]
6. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity.
Shi Q; Wang D; Hadley GA; Bingaman AW; Bartlett ST; Farber DL
Diabetes; 2004 Sep; 53(9):2338-45. PubMed ID: 15331543
[TBL] [Abstract][Full Text] [Related]
7. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
[TBL] [Abstract][Full Text] [Related]
8. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
9. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
[TBL] [Abstract][Full Text] [Related]
10. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.
Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD
Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371
[TBL] [Abstract][Full Text] [Related]
11. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
12. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121
[TBL] [Abstract][Full Text] [Related]
13. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
[TBL] [Abstract][Full Text] [Related]
14. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
Luo X; Yang H; Kim IS; Saint-Hilaire F; Thomas DA; De BP; Ozkaynak E; Muthukumar T; Hancock WW; Crystal RG; Suthanthiran M
Transplantation; 2005 May; 79(9):1091-6. PubMed ID: 15880049
[TBL] [Abstract][Full Text] [Related]
15. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
16. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
18. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice.
Yolcu ES; Zhao H; Bandura-Morgan L; Lacelle C; Woodward KB; Askenasy N; Shirwan H
J Immunol; 2011 Dec; 187(11):5901-9. PubMed ID: 22068235
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
